Patent details

Basic Information

Publication number:

EP3246021

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP171758642

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

APIXABAN FORMULATIONS

French Title of Invention:

FORMULATIONS D'APIXABAN

German Title of Invention:

APIXABAN-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

24/02/2011

Grant date:

13/11/2019

EP Publication Date:

22/11/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/11/2019

EP B1 Publication Date:

13/11/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/02/2031

Renunciation date:

Revocation date:

21/12/2023

Annulment date:

Owner

From:

06/11/2019

 

 

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312 Steinhausen, Switzerland (CH)

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

18/12/2019

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

PATEL, Jatin

Address:

United States (US)

2

Name:

JIA, Jingpin

Address:

United States (US)

3

Name:

FROST, Charles

Address:

United States (US)

4

Name:

VEMA-VARAPU, Chandra

Address:

United States (US)

Priority

Priority Number:

308056 P

Priority Date:

25/02/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 31/4545; A61P 7/02;

Publication

Bulletin

Bulletin Heading:

VRV

Bulletin edition number:

2024/06

Publication date:

06/05/2024

Description:

Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:

201946

Publication date:

13/11/2019

Description:

Grant (B1)

2

Issue number:

202039

Publication date:

23/09/2020

Description:

Opposition procedure started

3

Issue number:

202037

Publication date:

09/09/2020

Description:

Opposition procedure started

4

Issue number:

202417

Publication date:

24/04/2024

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

13/02/2024

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
18/12/2019	Power Of Attorney	1
18/12/2019	Outgoing Correspondence	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56